How has been the historical performance of Aster DM Health.?
Aster DM Health's historical performance shows fluctuating financial metrics, with net sales increasing from INR 2,994.05 crore in March 2023 to INR 4,138.46 crore in March 2025, and a significant rise in consolidated net profit from INR 424.91 crore to INR 5,377.83 crore during the same period, despite changes in liabilities and cash flow management.
Answer:The historical performance of Aster DM Health shows significant fluctuations in key financial metrics over the years.Breakdown:
Aster DM Health's net sales have shown a steady increase from INR 2,994.05 crore in March 2023 to INR 4,138.46 crore in March 2025, following a peak of INR 10,253.28 crore in March 2022. The total operating income mirrored this trend, rising from INR 2,994.05 crore in March 2023 to INR 4,138.46 crore in March 2025. However, total expenditure, excluding depreciation, also increased from INR 2,544.97 crore in March 2023 to INR 3,373.93 crore in March 2025, impacting the operating profit, which rose from INR 449.08 crore in March 2023 to INR 764.53 crore in March 2025. Profit before tax improved significantly from INR 206.68 crore in March 2023 to INR 489.97 crore in March 2025, while profit after tax increased from INR 170.81 crore to INR 355.60 crore during the same period. The consolidated net profit surged dramatically from INR 424.91 crore in March 2023 to INR 5,377.83 crore in March 2025, indicating a substantial improvement in profitability. On the balance sheet, total liabilities decreased from INR 17,982.66 crore in March 2024 to INR 6,600.17 crore in March 2025, while total assets also declined from INR 17,982.66 crore to INR 6,600.17 crore in the same timeframe. Cash flow from operating activities showed a positive trend, increasing from INR 157 crore in March 2024 to INR 425 crore in March 2025, while cash and cash equivalents at the end of March 2025 stood at INR 164 crore, up from INR 697 crore in March 2024. Overall, Aster DM Health's financial performance reflects a complex interplay of growth in sales and profits alongside significant changes in liabilities and cash flow management.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
